Voyager Therapeutics, Inc.
VYGR
Revenue
29.58M
▲10.06M▲51.56%
3 Months ChangeAssets
436.23M
▼-33.37M▼-7.11%
3 Months ChangeLiabilities
100.81M
▼-27.90M▼-21.68%
3 Months ChangeFree Cash Flow
56.63M
▼-66.43M▼-53.98%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-05
Form 8-K
ID: 0001104659-24-097152
2024-08-06
Form 10-Q
ID: 0001558370-24-011073
2024-08-06
Form 8-K
ID: 0001558370-24-011071
2024-06-13
Form 8-K
ID: 0001104659-24-071048
2024-06-06
Form 8-K
ID: 0001104659-24-069063
2024-05-16
Form 8-K
ID: 0001104659-24-062257
2024-05-13
Form 10-Q
ID: 0001558370-24-007953
2024-05-13
Form 8-K
ID: 0001558370-24-007951
2024-04-02
Form 8-K
ID: 0001104659-24-042502
2024-03-13
Form 8-K
ID: 0001104659-24-033726